Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Sep;115(9):2305-15.
doi: 10.1172/JCI26381.

Mechanisms of sudden cardiac death

Affiliations
Review

Mechanisms of sudden cardiac death

Michael Rubart et al. J Clin Invest. 2005 Sep.

Abstract

Despite recent advances in preventing sudden cardiac death (SCD) due to cardiac arrhythmia, its incidence in the population at large has remained unacceptably high. Better understanding of the interaction among various functional, structural, and genetic factors underlying the susceptibility to, and initiation of, fatal arrhythmias is a major goal and will provide new tools for the prediction, prevention, and therapy of SCD. Here, we review the role of aberrant intracellular Ca handling, ionic imbalances associated with acute myocardial ischemia, neurohumoral changes, and genetic predisposition in the pathogenesis of SCD due to cardiac arrhythmia. Therapeutic measures to prevent SCD are also discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Temporal relationship between ECG and single cardiomyocyte action potential. (A) The waves and intervals of a normal ECG. (B) Schematic representation of a ventricular action potential and its major underlying ionic currents. The downward arrow indicates influx; the upward arrow, efflux.
Figure 2
Figure 2
Schematic illustration of intracellular Ca2+ cycling and associated second messenger pathways in cardiomyocytes (figure modified from ref. 84). AC, adenylyl cyclase; α, G protein subunit α; α-receptor, α-adrenergic receptor; β, G protein subunit β; β-receptor, β-adrenergic receptor; γ, G protein subunit γ; LTCC, L-type Ca2+ channel; CAMKII, Ca2+-calmodulin kinase II; I-1, inhibitor 1; NCX, Na+/Ca2+ exchanger; P, phosphate group; PLC, phospholipase C; PLN, phospholamban; PP1, protein phosphatase 1; PP2A, protein phosphatase 2A; SERCA2a, SR Ca2+-ATPase isoform 2a; T-tubule, transverse tubule.
Figure 3
Figure 3
Proposed scheme of events leading to DADs and triggered tachyarrhythmia. (A) Congenital (e.g., ankyrin-B mutation) and/or acquired factors (e.g., ischemia, hypertrophy, increased sympathetic tone) will cause a diastolic Ca2+ leak through RyR2, resulting in localized and transient increases in [Ca2+]i in cardiomyocytes. (B) Representative series of images showing changes in [Ca2+]i during a Ca2+ wave in a single cardiomyocyte loaded with a Ca2+-sensitive fluorescent dye. Images were obtained at 117-ms intervals. Focally elevated Ca2+ (ii) diffuses to adjacent junctional SR, where it initiates more Ca2+ release events, resulting in a propagating Ca2+ wave (iii–viii). Reproduced with permission from Biophysical Journal (85). (C) The Ca2+ wave, through activation of Ca2+-sensitive inward currents, will depolarize the cardiomyocyte (DAD). In cardiomyocytes, the inward INa/Ca is the major candidate for the transient inward current underlying DADs, although the role of the Ca2+-activated Cl current [ICl(Ca)] and a Ca2+-sensitive nonspecific cation current [INS(Ca)] cannot be excluded. If of sufficient magnitude, the DAD will depolarize the cardiomyocyte above threshold resulting in a single or repetitive premature heartbeat (red arrows), which can trigger an arrhythmia. Downregulation of the inward rectifier potassium current (IK1), upregulation of INa/Ca, or a slight increase in intercellular electrical resistance can promote the generation of DAD-triggered action potentials. S, stimulus. Modified with permission from Circulation Research (26) and Nature (12).
Figure 4
Figure 4
Proposed scheme of events leading to transmembrane ionic imbalances during myocardial ischemia. Net intracellular Na+ gain due to a mismatch of Na+ influx and efflux will cause net cellular K+ loss, extracellular K+ accumulation, and an increase in intracellular Ca2+ due to activation of the Na+/Ca2+ exchanger operating in the reverse mode. Cellular Ca2+ overload will cause triggered arrhythmias by the mechanisms illustrated in Figure 3. Lysophosphatidylcholine is a product of diacyl phospholipid catabolism generated by the enzyme phospholipase A2 during ischemia. Question marks indicate that the pathway/mechanism is hypothetical. [ATP]i, intracellular concentration of adenosine triphosphate; Cx43, connexin-43; [H+]i, intracellular proton concentration; IK, delayed rectifier K+ current; IK,ATP, ATP-sensitive potassium current; IK1, inward rectifier K+ current; INa, fast Na+ current; Na/H, sodium-hydrogen exchanger; [K+]o, extracellular K+ concentration; TTX, tetrodotoxin (a specific blocker of the fast sodium current).
Figure 5
Figure 5
Factors contributing to arrhythmogenesis in hearts with heterogeneous sympathetic innervation. Myocardial injury (e.g., myocardial infarction) or chronic hypercholesterolemia (51) will cause a spatially uneven increase in sympathetic nerve density in the heart, resulting in regional variations in release and, consequently, variations in tissue levels of sympathetic neurotransmitters. Chronic, nonuniform elevations of neurotransmitters, through alterations in the expression of L-type Ca2+ channels and K+ channels, create spatial dispersion of action potential duration. Action potential prolongation and augmented Ca2+ influx through L-type Ca2+ channels combine to increase the susceptibility to EAD- and/or DAD-triggered activity in hyperinnervated regions. If the triggered beat propagates throughout the rest of the heart, the preexisting spatial dispersion of action potential duration and, thus, myocardial refractoriness facilitate the initiation of tachyarrhythmias. Locally elevated levels of neuropeptide Y and norepinephrine may increase coronary artery tone, thereby critically reducing the coronary perfusion reserve under conditions of increased oxygen demand (e.g., physical and/or emotional stress) and causing regional ischemia, which contributes to the development of an arrhythmia.

Similar articles

Cited by

References

    1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 2001;345:1473–1482. - PubMed
    1. Yadav AV, Das M, Zipes DP. Selection of patients for ICDs: ‘where are we in 2005?’. ACC Curr. J. Review. 2005;14:33–37.
    1. Echt DS, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med. 1991;324:781–788. - PubMed
    1. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N. Engl. J. Med. 1998;339:489–497. - PubMed
    1. Alberte C, Zipes DP. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J. Cardiovasc. Electrophysiol. 2003;14:S87–S95. - PubMed

Publication types

MeSH terms